Still, should a genetic test for FGFR2 be developed and offered to women? And if so–at what cost? Current genetic testing costs upwards of $3,000 or more, and many insurance companies won’t cover it. Listen to Dr. Hunter: don’t call your local cancer center to ask for genetic testing just yet. “It is premature to recommend screening women for these gene variants, at least until the scientific community has…found all the variants that are associated with increased risk,” he said. Bottom line: be patient. An expansion of genetic testing may be down the road, but for now, only those with a strong family history of breast cancer, or other indicating factors, need to be tested.